Skip to content

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Bowel Preparation Before Colonoscopy: A Multicentre, Randomized, Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06728839
Enrollment
1329
Registered
2024-12-11
Start date
2024-12-09
Completion date
2025-08-31
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation for Colonoscopy

Keywords

Magnesium sulfate, colonoscopy, bowel preparation, adenoma detection rate

Brief summary

Magnesium salts such as magnesium citrate are often combined with polyethylene glycol to make the intestinal preparation before colonoscopy, which has shown high cleaning efficacy. Magnesium sulfate combined with polyethylene glycol is less used in the world. This multicenter, randomized, controlled trial is aimed at to evaluate the efficacy and safety of magnesium sulfate combined with low-volume polyethylene glycol for preoperative bowel preparation for colonoscopy.

Interventions

DRUG1L PEG + 50g magnesium sulfate

Subjects in Group A will use a regimen combining magnesium sulfate and polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. 1 litter of polyethylene glycol is taken at 8pm the day before the colonoscopy and 50 gram of magnesium sulfate is taken 4-6 hours before the colonoscopy, and then drink 2000 ml of water within 2 hours.

DRUG3L PEG

Subjects in Group B will use a regimen with 3L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 3 liters of polyethylene glycol solution is taken in split dosing, with 1 liter taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.

DRUG4L PEG

Subjects in Group C will use a regimen with 4L polyethylene glycol for preoperative bowel preparation and undergo colonoscopy. The 4 liters of polyethylene glycol solution is taken in split dosing, with 2 liters taken at 8pm the day before the colonoscopy and 2 liters taken 4-6 hours before the colonoscopy.

Sponsors

The First Affiliated Hospital of Nanchang University
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
The Second Hospital of Hebei Medical University
CollaboratorOTHER
Daping Hospital of Army Medical University
CollaboratorOTHER
Ningjin People's Hospital
CollaboratorUNKNOWN
Zibo Central Hospital
CollaboratorOTHER_GOV
Zhengzhou Central Hospital
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Affiliated Yueqing Hospital of Wenzhou Medical University
CollaboratorOTHER
Qianfoshan Hospital
CollaboratorOTHER
The General Hospital of Western Theater Command
CollaboratorOTHER
Jiangmen Central Hospital
CollaboratorOTHER
The First Affiliated Hospital of Henan University of Science and Technology
CollaboratorOTHER
LiuZhou People's Hospital
CollaboratorOTHER
The Fifth Affiliated Hospital of Zunyi Medical College
CollaboratorOTHER
Yan'an University Affiliated Hospital
CollaboratorOTHER
900 Hospital of Joint Logistics Support Force of PLA
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-75 years old, male or female * To undergo screening, surveillance and diagnostic colonoscopy * Signed written informed consent

Exclusion criteria

* Subjects with therapeutic colonoscopy for colorectal polyps * Subjects with confirmed or suspected gastrointestinal obstruction, gastric retention, gastroparesis, gastric emptying disorder, or acute gastrointestinal bleeding * Subjects with confirmed or suspected colorectal cancer, inflammatory bowel disease, toxic colitis, or toxic megacolon * Subjects with renal or liver dysfunction, congestive heart failure or rhabdomyolysis * Subjects with ascites, suspected electrolyte abnormalities, or uncorrected dehydration * Subjects with constipation (\<3 times a week, difficult defecation, dry stool, less amount) * Subjects with serious cardiac and cerebrovascular diseases,suffering from metabolic disease or endocrine disease * Subjects who had previously undergone colorectal resection * Women with positive pregnancy tests or pregnancy plans, and women in lactation or allergic to the investigational drugs and their ingredients * Subjects who are participating in other clinical trials or receiving special drugs * Subjects with any other conditions that the investigator considered inappropriate for inclusion

Design outcomes

Primary

MeasureTime frameDescription
Adequate bowel preparation rate30minutesDefined as the proportion of participants with score ≥ 2 for all colon segment (right-side colon, transverse colon, and left-side colon) according to the Boston Bowel Preparation Scale

Secondary

MeasureTime frameDescription
Excellent bowel preparation rate30minutesThe proportion of participants with total score ≥ 8 according to Boston Bowel Preparation Scale.
BBPS score (including total score, left colon, transverse colon, and right colon)30minutes
Adenoma detection rate10 days
Bowel preparation completion rate30minutes
Electrolyte levels8 hours

Contacts

Primary ContactZhaoshen Li, MD
li.zhaoshen@hotmall.com86-021-31161365
Backup ContactYu Bai, MD
baiyu1998@hotmail.com86-021-31161335

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026